LOS ANGELES, Nov. 1, 2007 (PRIME NEWSWIRE) -- Universal Detection Technology (http://www.udetection.com) (OTCBB:UDTT), a developer and provider of early-warning monitoring technologies to protect people from bioterrorism and radiological weapons, has signed a memorandum of understanding (MOU) with EMME Consulting. The MOU lays out the framework for UDT and EMME Consulting to jointly test their technologies at hospital and school environments for detection and decontamination of Methicillin-Resistant Staphylococcus Aureus (MRSA).
According to the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services, five percent of the some 368,600 patients treated in U.S. hospitals for MRSA in 2005 died. Also, according to a recent report by the Centers for Disease Control and Prevention, MRSA is responsible for more than 94,000 serious infections and nearly 19,000 deaths each year. Recent reports also indicate the spread of MRSA in schools throughout the country.
"Some hospitals are taking more aggressive steps in combating MRSA by testing all patients for MRSA," said Mr. Amir Ettehadieh, UDTT's Director of Research and Development. "We expect our partnership with EMME, a firm with strong connections with hospitals in metropolitan Detroit, to give us an opportunity to test our microbial monitor in a hospital setting," he added.
For more information please visit http://www.udetection.com or Email us at info@udetection.com.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain bio hazard substances. For more information, please visit http://www.udetection.com.
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.